Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
December 3, 2025 Off

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

By GlobeNewswire

MONTREAL and CHARLOTTE, N.C., Dec. 02, 2025 (GLOBE NEWSWIRE) — Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today…

December 3, 2025 Off

New Data Presented at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF

By GlobeNewswire

TOKYO and CAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and…

December 3, 2025 Off

Verano Awarded Conditional License to Commence Vertical Cannabis Operations in Texas

By GlobeNewswire

Subject to final state approval, the Dispensing Organization License grants Verano permission to cultivate, process and dispense medical cannabis across…

December 3, 2025 Off

FibroGen to Present at the Oppenheimer Movers in Rare Disease Summit

By GlobeNewswire

SAN FRANCISCO, Dec. 02, 2025 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending…

December 3, 2025 Off

Zymeworks Announces Participation in Upcoming Conferences

By GlobeNewswire

• Late-breaking HERIZON-GEA-01 presentation at ASCO GI highlights the expanding clinical profile of Ziihera® across HER2-driven gastrointestinal cancers by partner…

December 3, 2025 Off

Thermo Fisher Scientific Deepens Investment in Asia’s Biopharma Ecosystem with Expansion of Bioprocess Design Centers

By BusinessWire

New and expanded facilities provide local expertise, advanced technologies and tailored support for biopharma innovators throughout the region WALTHAM, Mass.–(BUSINESS…

December 2, 2025 Off

Bispecific Antibodies Market Industry Trends and Global Forecasts, 2035: Multi-Billion Dollar Expansion Driven by Rising Cancer Burden, Personalized Medicine Demand, and Expanding R&D Initiatives – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Bispecific Antibodies Market Industry Trends and Global Forecasts to 2035: By Therapeutic Area, Mechanism of Action, Target Antigen,…

December 2, 2025 Off

Buffer Preparation Market Industry Trends and Global Forecasts to 2035: Market Strengthens With 60+ Systems and 70+ Service Providers – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Buffer Preparation Market Industry Trends and Global Forecasts to 2035: Distribution by Scale of Operation, Type of System…

December 2, 2025 Off

Middle East Cell and Gene Therapy CDMO Market Forecast to 2033 Featuring Strategic Profiles of Key Players – Porton Advanced, WuXi AppTec, Thermo Fisher Scientific, Charles River Labs, Lonza and More – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Middle East Cell and Gene Therapy CDMO Market Forecast to 2033” has been added to ResearchAndMarkets.com’s offering. The…

December 2, 2025 Off

Compounding Pharmacy Market Trends and Strategy Outlook to 2030 – The Pain Management Segment Dominates Pharmaceutical Applications with Targeted Therapies – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Compounding Pharmacy Market by Product (Oral, Topical, Parenteral), Compounding Type (Ingredient Alteration, Dosage Alteration), Therapeutic Application (Pain Management,…

Posts pagination

Previous 1 … 7 8 9 … 6,180 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)

December 5, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine